Key facts
- Particle Dynamics Holdings’s last known valuation is $70.0M (Sep 2025).
- It has raised $30.9M across 1 recorded rounds; the latest was Early Stage VC ($30.9M) in Sep 2025.
- Notable investors include 1315 Capital, BroadOak Capital Partners, Research Corporation Technologies.
- Particle Dynamics Holdings has filed 1 Form D with the SEC, most recently Oct 2025 ($30.9M sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Particle Dynamics Holdings
Funding rounds
1 roundsAbout Particle Dynamics Holdings
Operator of a contract pharmaceutical manufacturing company intended to serve the pharmaceutical, consumer health, OTC and nutraceutical products companies. The company specializes in active pharmaceutical ingredients such as calcium carbonate and magnesium carbonate, enabling clients to get reliable products for the production unit.
- Sector
- Healthcare
- HQ
- Saint Louis, MO, United States
- Founded
- 1990
- Employees
- 80
- Website
- codis.com/
- Ownership
- Privately Held (backing)
Particle Dynamics Holdings doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Particle Dynamics Holdings shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Particle Dynamics Holdings in its N-PORT filings yet. We sweep new filings monthly.